IOmx Therapeutics AG | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
IOmx Therapeutics AG

BRIEF

published on 08/22/2024 at 10:05, 2 months 30 days ago

IOmx Therapeutics Initiates Phase Ib with OMX-0407

Cancer Therapy Clinical Trial IOmx Therapeutics OMX-0407 Phase Ib
PRESS RELEASE

published on 08/22/2024 at 10:00, 2 months 30 days ago

iOmx Therapeutics Initiates Phase Ib with OMX-0407
iOmx Therapeutics initiates Phase Ib clinical trial with OMX-0407, showing favorable safety profile and anti-tumor activity in solid tumors. Expansion phase opens in kidney cancer and angiosarcoma

Solid Tumors Clinical Trial IOmx Therapeutics OMX-0407 Phase Ib
BRIEF

published on 06/27/2024 at 10:05, 4 months 24 days ago

IOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer

Chief Financial Officer Biopharmaceutical Leadership IOmx Therapeutics Florian Schmid
PRESS RELEASE

published on 06/27/2024 at 10:00, 4 months 24 days ago

iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer
iOmx Therapeutics appoints Florian Schmid as new Chief Financial Officer, succeeding Marcus Irsfeld. Schmid brings 20+ years of financial leadership experience in biopharma. Company aims to advance immuno-oncology drug candidates

Chief Financial Officer Biopharmaceutical Immuno-oncology IOmx Therapeutics Florian Schmid
PRESS RELEASE

published on 11/01/2023 at 10:00, 1 year ago

iOmx Therapeutics attends upcoming scientific and industry conferences
PRESS RELEASE

published on 09/05/2023 at 08:30, 1 year 2 months ago

iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer
PRESS RELEASE

published on 04/04/2023 at 10:00, 1 year 7 months ago

iOmx Therapeutics Announces Dosing of First Patient with SIK Inhibitor OMX-0407 in Phase I Clinical Trial
PRESS RELEASE

published on 02/23/2023 at 10:00, 1 year 8 months ago

iOmx Therapeutics appoints Dr. Christine Rothe as new Chief Development Officer

Accesswire

Published on 11/21/2024 at 10:03, 40 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 43 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 43 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 8 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 18 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 13 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 38 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 41 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 43 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 43 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE